Recommended Citation
Natour AK, Shepard AD, Nypaver T, Cuff R, Mouawad NJ, Mattos M, Henke P, and Kabbani L. Utilization Of Preoperative Vein Mapping In Patients Undergoing Infra-inguinal Bypass Is Associated With Increased Use Of Venous Conduits. J Vasc Surg 2022; 76(4):e53-e54.
Document Type
Conference Proceeding
Publication Date
10-1-2022
Publication Title
J Vasc Surg
Abstract
Objective: The objective of this study was to determine if preoperative vein mapping (PVM) was associated with increased use of autogenous venous conduits in a real-world registry of lower extremity infra inguinal bypass (IIB).
Methods: A retrospective review of a statewide vascular surgery registry was queried for all patients between 2012 and 2020 who underwent IIB. We excluded trauma patients and patients with acute limb ischemia, and previous lower extremity bypasses. Preoperative and intraoperative variables were analyzed, and postoperative outcomes were correlated with the use of PVM.
Results: A total of 5540 patients were included in the study. The average age was 67 years. Sixty-nine percent of the cohort were male, and 81% were white. PVM was performed on 2532 patients (45%). Patients who underwent PVM were more likely to be white (83% vs 79%; P <.001) and have commercial insurance (24% vs 21%; P =.001). A venous conduit was significantly more likely to be used in patients who underwent preoperative vein mapping (69% vs 28%; P <.001). When looking at patients who underwent IIB with a venous conduit, intraoperative blood loss was significantly less, and 30-day transfusion tended to be lower in patients who had PVM (290 vs 323 mL; P =.032; 30% vs 26%; P =.07, respectively), although no significant difference was seen with the length of procedure (P =.44). Intraoperative angiogram/duplex ultrasonography to establish technical adequacy was more commonly used in the PVM subgroup (39% vs 32%; P <.001) and was more likely to be reported as normal. No significant difference was found in terms of short-term outcomes (length of stay; neurologic, renal, or cardiac complications; 30-day patency; readmission; and death) or for surgical site infection variables (30-day readmission for wound infection, need to return to operating room for infection).
Conclusions: Most patients do not have PVM before their IIB. Patients who undergo PVM are more than twice as likely to have a venous conduit used for their bypass. In patients who underwent autogenous venous conduit bypass, postoperative imaging to establish technical adequacy was performed more frequently in patients who underwent PVM and was more likely to be reported as normal. Despite no change in 30-day or 1-year patency, PVM may be a marker for physicians who are interested in best practices for IIB.
Volume
76
Issue
4
First Page
e53
Last Page
e54
